Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis

Veure altres versions (1)

Interferon-β (IFN-β) drugs are considered to derive their beneficial effects on multiple sclerosis (MS) progression via their antiinflammatory properties, but the precise mechanism of action remains unclear. Here, we sought to discover how IFN-β impacts on inflammation-associated aggravation of MS-l...

Descripció completa

Dades bibliogràfiques
Autors principals:	Serres, S, Bristow, C, De Pablos, R, Merkler, D, Soto, MS, Sibson, N, Anthony, D
Format:	Journal article
Idioma:	English
Publicat:	2013

Ítems similars

Magnetic resonance imaging reveals therapeutic effects of interferon-beta on cytokine-induced reactivation of rat model of multiple sclerosis.
per: Serres, S, et al.
Publicat: (2013)

Contribution of peripheral IL-1beta expression in the systemic reactivation of focal MOG-EAE lesions in rat brain
per: Serres, S, et al.
Publicat: (2009)

CONTRIBUTION OF PERIPHERAL IL-1BETA EXPRESSION IN THE SYSTEMIC REACTIVATION OF FOCAL MOG-EAE LESIONS IN RAT BRAIN
per: Serres, S, et al.
Publicat: (2009)

Interferon beta treatment of multiple sclerosis.
per: Markovitz, D
Publicat: (1994)

VCAM-1-targeted magnetic resonance imaging reveals subclinical disease in a mouse model of multiple sclerosis.
per: Serres, S, et al.
Publicat: (2011)

Beta-interferons in multiple sclerosis
per: Aggarwal Sourabh, et al.
Publicat: (2010-01-01)

PHARMACOGENETICS OF INTERFERON BETA IN MULTIPLE SCLEROSIS
per: Mohamed Rayen Ganouni, et al.
Publicat: (2023-10-01)

Reactivation of a focal EAE lesion by a systemic inflammatory response
per: Serres, S, et al.
Publicat: (2007)

Functional role of endothelial adhesion molecules in the early stages of brain metastasis.
per: Soto, MS, et al.
Publicat: (2014)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
per: Sibley, W, et al.
Publicat: (1994)

Detection of primary and secondary brain tumours using molecularly-targeted magnetic resonance imaging
per: Serres, S, et al.
Publicat: (2016)

Treatment of multiple sclerosis with interferon beta-1b - Reply
per: Sibley, W, et al.
Publicat: (1997)

Treatment of multiple sclerosis with interferon beta-1 b.
per: Abdul-Ahad, A, et al.
Publicat: (1997)

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
per: Castrop F, et al.
Publicat: (2013-09-01)

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines
per: Carlos B. Tauil, et al.
Publicat: (2020-12-01)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
per: Sørensen, P, et al.
Publicat: (2010)

A cost-utility analysis of interferon beta for multiple sclerosis.
per: Parkin, et al.
Publicat: (1998-01-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
per: Masoud Mohammad Malekzadeh, et al.
Publicat: (2020-06-01)

THE INFLUENCE OF NEUTRALIZING ANTIBODIES TO INTERFERON-BETA ON PROGRESSION OF MULTIPLE SCLEROSIS
per: V. Yu. Lizhdvoy, et al.
Publicat: (2016-07-01)

Levels of circulating cytokines in children with multiple sclerosis with different effectiveness of interferon therapy
per: T. V. Radygina, et al.
Publicat: (2024-01-01)

Comparison of MRI signatures in pattern I and II multiple sclerosis models.
per: Serres, S, et al.
Publicat: (2009)

Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy
per: A. D. Kukushkina, et al.
Publicat: (2024-08-01)

Proteotranscriptomic analyses reveal distinct interferon-beta signaling pathways and therapeutic targets in choroidal neovascularization
per: Yuxiang Hu, et al.
Publicat: (2023-03-01)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
per: Lampasona, V, et al.
Publicat: (2003)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
per: Ebers, G, et al.
Publicat: (1997)

Interferon-beta for relapsing-remitting multiple sclerosis: a systematic review
per: Dian HE, et al.
Publicat: (2014-09-01)

Influence of Interferon beta treatment on quality of life in multiple sclerosis patients
per: De Caro Maria, et al.
Publicat: (2006-12-01)

Beta-interferons in multiple sclerosis: A single center experience in India
per: Gupta Salil, et al.
Publicat: (2010-01-01)

Interferon beta: Medication which started the revolution in the treatment of multiple sclerosis
per: Ivanović Jovana, et al.
Publicat: (2019-01-01)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
per: Elmazny A, et al.
Publicat: (2020-03-01)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
per: Cocco E, et al.
Publicat: (2015-05-01)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
per: Ebers, G, et al.
Publicat: (1998)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
per: Mark S. Freedman, et al.
Publicat: (2024-01-01)

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis
per: Parry, A, et al.
Publicat: (2002)

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
per: Parry, A, et al.
Publicat: (2003)

Reversible Pulmonary Arterial Hypertension Associated with Interferon-Beta Treatment for Multiple Sclerosis
per: E Gibbons, et al.
Publicat: (2015-01-01)

Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis
per: Alexandre Xavier, et al.
Publicat: (2023-05-01)

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
per: Miraç Ayşen Ünsal
Publicat: (2019-03-01)

The Effect of Beta Interferon on the Expression of miR-145 in Patients with Multiple Sclerosis
per: Naeim Ehtesham, et al.
Publicat: (2016-11-01)

Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
per: Keivan Basiri, et al.
Publicat: (2012-02-01)